Loading stock data…
$1.09-0.02 (-1.80%)
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America.
Firefly Neuroscience, Inc. in the Technology sector is trading at $1.09 with a market capitalization of $20M. The stock is currently near its 52-week low of $0.62, remaining 20.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $514,000↑ | $485,000↑ | $412,000↑ | $388,000↑ | $299,000 |
| Gross Profit | $253,000↑ | $221,000↑ | $182,000↑ | $146,000↓ | $274,000 |
| Operating Income | -$1.97M↑ | -$2.01M↑ | -$2.40M↑ | -$2.50M↓ | -$1.63M |
| Net Income | -$1.98M↑ | -$2.00M↑ | -$2.48M↑ | -$2.64M↓ | -$1.83M |
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the huma...